These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35304349)

  • 1. Paying Homage to the Power of Proteomics: Insights Into Obesity and Heart Failure From the HOMAGE Trial.
    Harrington J; Tseliou E; Shah S; Shah KS
    J Card Fail; 2022 May; 28(5):787-788. PubMed ID: 35304349
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial.
    Verdonschot JAJ; Ferreira JP; Pizard A; Pellicori P; Brunner La Rocca HP; Clark AL; Cosmi F; Cuthbert J; Girerd N; Waring OJ; Henkens MHTM; Mariottoni B; Petutschnigg J; Rossignol P; Hazebroek MR; Cleland JGF; Zannad F; Heymans SRB;
    J Card Fail; 2022 May; 28(5):778-786. PubMed ID: 34933097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.
    Verdonschot JAJ; Ferreira JP; Pellicori P; Brunner-La Rocca HP; Clark AL; Cosmi F; Cuthbert J; Girerd N; Mariottoni B; Petutschnigg J; Rossignol P; Cleland JGF; Zannad F; Heymans SRB;
    Cardiovasc Diabetol; 2021 Aug; 20(1):163. PubMed ID: 34372849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
    Pellicori P; Ferreira JP; Mariottoni B; Brunner-La Rocca HP; Ahmed FZ; Verdonschot J; Collier T; Cuthbert JJ; Petutschnigg J; Mujaj B; Girerd N; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Latini R; Rossignol P; Zannad F; Cleland JGF
    Eur J Heart Fail; 2020 Sep; 22(9):1711-1723. PubMed ID: 31950604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
    Ravassa S; López B; Ferreira JP; Girerd N; Bozec E; Pellicori P; Mariottoni B; Cosmi F; Hazebroek M; Verdonschot JAJ; Cuthbert J; Petutschnigg J; Moreno MU; Heymans S; Staessen JA; Pieske B; Edelmann F; Clark AL; Cleland JGF; Zannad F; Díez J; González A;
    Eur J Heart Fail; 2022 Feb; 24(2):321-331. PubMed ID: 34841615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
    Ferreira JP; Verdonschot J; Wang P; Pizard A; Collier T; Ahmed FZ; Brunner-La-Rocca HP; Clark AL; Cosmi F; Cuthbert J; Díez J; Edelmann F; Girerd N; González A; Grojean S; Hazebroek M; Khan J; Latini R; Mamas MA; Mariottoni B; Mujaj B; Pellicori P; Petutschnigg J; Pieske B; Rossignol P; Rouet P; Staessen JA; Cleland JGF; Heymans S; Zannad F;
    JACC Heart Fail; 2021 Apr; 9(4):268-277. PubMed ID: 33549556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
    Monzo L; Ferreira JP; Cleland JGF; Pellicori P; Mariottoni B; Verdonschot JAJ; Hazebroek MR; Collier TJ; Cuthbert JJ; Pieske B; Edelmann F; Petutschnigg J; Khan J; Ahmed FZ; Girerd N; Bozec E; Díez J; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Rossignol P; Zannad F
    ESC Heart Fail; 2022 Dec; 9(6):4352-4357. PubMed ID: 36065795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
    Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; Clark AL; Cosmi F; Cuthbert J; Diez J; Edelmann F; Hazebroek M; Heymans S; Mariottoni B; Pellicori P; Petutschnigg J; Pieske B; Staessen JA; Verdonschot JAJ; Rossignol P; Cleland JGF; Zannad F
    Eur J Heart Fail; 2022 Sep; 24(9):1559-1568. PubMed ID: 35703355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial.
    Ferreira JP; Cleland JGF; Girerd N; Pellicori P; Hazebroek MR; Verdonschot J; Collier TJ; Petutschnigg J; Clark AL; Staessen JA; Heymans S; Zannad F; Rossignol P
    Clin Res Cardiol; 2023 Feb; 112(2):330-332. PubMed ID: 36279002
    [No Abstract]   [Full Text] [Related]  

  • 10. Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.
    Ferreira JP; Collier T; Clark AL; Mamas MA; Rocca HB; Heymans S; González A; Ahmed FZ; Petutschnigg J; Mujaj B; Cuthbert J; Rouet P; Pellicori P; Mariottoni B; Cosmi F; Edelmann F; Thijs L; Staessen JA; Hazebroek M; Verdonschot J; Rossignol P; Girerd N; Cleland JG; Zannad F
    Eur Heart J Cardiovasc Pharmacother; 2022 Feb; 8(2):149-156. PubMed ID: 33822033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
    Elkholey K; Papadimitriou L; Butler J; Thadani U; Stavrakis S
    Am J Cardiol; 2021 May; 146():36-47. PubMed ID: 33529620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.
    Cleland JGF; Ferreira JP; Mariottoni B; Pellicori P; Cuthbert J; Verdonschot JAJ; Petutschnigg J; Ahmed FZ; Cosmi F; Brunner La Rocca HP; Mamas MA; Clark AL; Edelmann F; Pieske B; Khan J; McDonald K; Rouet P; Staessen JA; Mujaj B; González A; Diez J; Hazebroek M; Heymans S; Latini R; Grojean S; Pizard A; Girerd N; Rossignol P; Collier TJ; Zannad F;
    Eur Heart J; 2021 Feb; 42(6):684-696. PubMed ID: 33215209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
    Ferreira JP; Verdonschot JAJ; Girerd N; Bozec E; Pellicori P; Collier T; Mariottoni B; Cosmi F; Hazebroek M; Cuthbert J; Petutschnigg J; Heymans S; Staessen JA; Pieske B; Edelman F; Clark AL; Díez J; González A; Rossignol P; Cleland JG; Zannad F
    Eur J Heart Fail; 2022 May; 24(5):771-778. PubMed ID: 35199421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics as a Path to More Refined Heart Failure Therapeutics.
    Januzzi JL; Murphy SP
    JACC Heart Fail; 2021 Apr; 9(4):278-280. PubMed ID: 33549553
    [No Abstract]   [Full Text] [Related]  

  • 15. Paying homage to pioneering women who paved the way.
    Sharp V
    Iowa Med; 2013; 103(5):4-5. PubMed ID: 25208444
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paying homage to Fleming, the father of penicillin].
    LAFAY B
    Prophyl Sanit Morale; 1955 Apr; 27(4):75-6. PubMed ID: 13310625
    [No Abstract]   [Full Text] [Related]  

  • 17. We mourn our great loss. Paying homage to Martin Delaney. 1945-2009.
    Berger DS
    Posit Aware; 2009; 20(2):16-7. PubMed ID: 19280740
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction: paying homage to my teacher: Karen Horney (1885-1952).
    Berger MM
    Am J Psychoanal; 1991 Sep; 51(3):191-207. PubMed ID: 1962686
    [No Abstract]   [Full Text] [Related]  

  • 19. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
    Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial.
    Lewis EF; Kim HY; Claggett B; Spertus J; Heitner JF; Assmann SF; Kenwood CT; Solomon SD; Desai AS; Fang JC; McKinlay SA; Pitt BA; Pfeffer MA;
    Circ Heart Fail; 2016 Mar; 9(3):e001937. PubMed ID: 26962133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.